Related Image: New theory on fairness in economics targets CEO pay |
(Date:11/19/2009)...year, multi-institutional effort co-led by three C...minated today in publication of a landmark series ...precedented detail the DNA sequence of maize ( Zea...by North American consumers, is one of the world,s...ultural crop grown in the United States, represent...
(Date:11/19/2009)... Sustainable farming, initially adopted to preserv...ay a role in maintaining a healthy climate, accord...ak Ridge and Los Alamos national laboratories. , ...potential of the earth,s soils to sequester carbon...ces could greatly reduce U.S. carbon emissions by ...
(Date:11/19/2009)...innati professor of paleontology in the McMicken C...oote of the University of Chicago publish their re...r paper, "Epicontinental Seas Versus Open-Ocean Se...ation." , For many years, paleobiological resear...ve focused on charting the many ups (evolutionary ...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Neurocrine Biosciences Secures Committed Equity Financing Facility 14065 1Neurocrine Biosciences Secures Committed Equity Financing Facility 14065 2Neurocrine Biosciences Secures Committed Equity Financing Facility 14065 3FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 1FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 2FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 3Celiac Disease May Raise Risk of Dying 57272 1(Date:11/19/2009)...rstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), anno...to its shareholders, discussing the Company,s acqu...uticals Holdings, Inc. (CHBP), an integrated bio-p...ic of China. The merger gives NeoStem a controllin...td., CHBP,s primary operating subsidiary and a pro...
(Date:11/19/2009)... Aegera Therapeutics Inc. announced today the dosi...tudy of AEG35156, a targeted antisense therapeutic...dications. ,, The study, entitled "An Open-Labe...or of Apoptosis (XIAP) Antisense AEG35156 Given in...cin in AML Following Failure of a Single Standard ...
(Date:11/19/2009)...r 19 AFFiRiS AG will focus its,Alz...at an unexpectedly early,stage of development: the...hase II clinical trial early in 2010. This decisio...n of two Phase I trials with the candidates,AD01 a...e first interim,analysis of the secondary endpoint...
(Date:11/18/2009)... postage stamp that can sniff out poisonous gases ... reported in the Sept. 13 issue of the journal Na...he University of Illinois have developed an artifi...trial chemicals (TICs) that is simple, fast and in...ensor array could be useful in detecting high expo...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3...nding of Operations Outside the US In ..., Md., Nov. 6 Northwest,Biotherapeutics, Inc. (OT...,announced that it has obtained US$1.65 million in...y Notes (the "Notes") with SDS Capital Group SPC,L...Private Investors"). A,significant portion of the ...
...nDance Technologies, Inc.,a provider of innovative...,disease research, today announced that it has shi...chment application to The Genome Center (GC) at,th...Louis, a world leader,in genomics research., Unde...nce will provide,its new RDT 1000 and expert train...
...lik, Inc.,(Nasdaq: TELK ) reported a net loss of ...arter ended September 30, 2008, compared with a ne...he comparable period in 2007. The,$8.0 million net...d to,corporate and municipal notes investments wit...ties, which is reflected in interest and other inc...
Other Biology Technology:Northwest Secures US$1.65 Million Debt Financing 2Northwest Secures US$1.65 Million Debt Financing 3Northwest Secures US$1.65 Million Debt Financing 4RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis 2Telik Announces Financial Results for 2008 Third Quarter 2Telik Announces Financial Results for 2008 Third Quarter 3Telik Announces Financial Results for 2008 Third Quarter 4Anti-Bunyavirus (G1) Monoclonal Antibody, Unconjugated, Clone 8C2.1 from CHEMICON
Rabbit Anti-BI-1 Polyclonal Antibody, Unconjugated from BioVision
Capped Xef-1 RNA 0.05 ml from Ambion
Human TIMP-1 ELISpot Kit from R&D Systems
Biology Products: